The Global Brain Computer Interface Market is estimated to be valued at USD 2.40 Bn in 2025 and is expected to reach USD 6.16 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% from ...
Every four years at the Cybathlon, teams of researchers and technology “pilots” compete to see whose brain-computer interface ...
Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.
A recent scientific preprint published by Paradromics reported that the Connexus implant – a tiny device that is implanted ...
A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...
The Cybathlon sees teams of researchers and technology ‘pilots’ compete to see whose brain-computer interface holds the most ...
Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...
Passwork 7 unifies enterprise password and secrets management in a self-hosted platform. Organizations can automate ...
Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...
Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...
Before a car crash in 2008 left her paralysed from the neck down, Nancy Smith enjoyed playing the piano. When she imagined ...